MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Frost & Sullivan
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Smartphone-based Solutions Boost Global Infectious Disease Point-of-Care Testing Market At An Explosive CAGR of 70.2% in 2020 Finds Frost & Sullivan - The emergence of cost-effective lab-on-a-chip and smartphone-based POCTs, alongside increasing reliance on less-invasive testing methodologies, will propel the POCT market - Frost.com
Smartphone-based Solutions Boost Global Infectious Disease Point-of-Care Testing Market At An Explosive CAGR of 70.2% in 2020 Finds Frost & Sullivan

 

NewswireToday - /newswire/ - Santa Clara, CA, United States, 2020/10/01 - The emergence of cost-effective lab-on-a-chip and smartphone-based POCTs, alongside increasing reliance on less-invasive testing methodologies, will propel the POCT market - Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Digital POCT platforms will enable diagnostic testing beyond the clinic, transforming how assay results are gathered and analyzed, finds Frost & Sullivan.

Frost & Sullivan’s recent analysis, Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024, finds that the outbreak of the COVID-19 pandemic has transformed the infectious disease point-of-care testing (POCT) market. The emergence of cost-effective lab-on-a-chip and smartphone-based POCTs, alongside increasing reliance on less-invasive testing methodologies, will propel the POCT market. Globally, the infectious disease POCT market is estimated to witness more than a three-fold growth, reaching $26.4 billion by 2024 from $7.9 billion in 2019, up at a compound annual growth rate (CAGR) of 27.3%.

“The POCT instrument selection process should involve close collaboration with supply and clinical engineering departments to incorporate their input and feedback,” said Amartya Bose, Healthcare Industry Analyst at Frost & Sullivan. “This is a key consideration when the POCT committee reviews all options and makes an informed decision. Hospitals/labs/pharmacies should select regional vendors for device procurement and services. This will reduce the procurement lead time and ensure devices are managed for quality assurance, timely calibrations, and interpretation of results.”

Nitin Naik, Life Sciences Vice President at Frost & Sullivan, added: “The application of artificial intelligence (AI) and machine learning (ML) is a key growth opportunity for manufacturers to enhance their product portfolios. By leveraging these platforms, POCT assay menus can be expanded for different patient groups by simply iterating the product development cycle. U.S. healthcare providers are also leveraging digital POCT along with virtual assistants to screen and triage asymptomatic patients.”

To capitalize on growth opportunities in the current and post-COVID-19 situation, POCT market participants should focus on the following solutions:

• Multiplexed POCT: Integrate sample preparation and analysis within one device to offer more advantages in a competitive environment.
• COVID-19 POCT: Develop accurate serology tests and mHealth-based diagnostics, as they will play a critical role in determining the disease’s full scope, combating the pandemic.
• Digital POCT: Adopt cloud technologies as an integral part of device development to reduce the footprint and cost of POCT devices.
• Millennials and sexually transmitted infections (STIs): Produce HIV/syphilis dual tests as evidence suggests a two- to five-fold increased risk of acquiring HIV if exposed to it when syphilis is present.

Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024 is the latest addition to Frost & Sullivan’s Healthcare research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For over five decades, Frost & Sullivan (frost.com) has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024 / K4C6

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Smartphone-based Solutions Boost Global Infectious Disease Point-of-Care Testing Market At An Explosive CAGR of 70.2% in 2020 Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Mariana Fernandez - Frost.com 
210-348-1012 mariana.fernandez[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Withings Health Solutions Launches Cellular Devices to Eliminate Telehealth Pain Points for Healthcare Professionals and Patients
ScImage Lauded by Frost & Sullivan for its Cloud-based Enterprise Imaging Platform, PICOM365
RapidAI Acclaimed by Frost & Sullivan for its AI-powered Modular Stroke Platform
Belgian Initiative for AI Lung Scan Analysis in Fight Against COVID-19 Goes European
EyeQue Acclaimed by Frost & Sullivan for its Wide Range of Consumer-friendly, Hand-held Ophthalmic Monitoring Solutions
Withings Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials
RapidAI Receives 2020 Global Company of the Year Award from Frost & Sullivan for its AI-Powered Stroke Imaging and Diagnosis Technologies
Withings Partners with Redox to Make Remote Patient Monitoring Seamless for Physicians and Hospitals
GHz-Class NMR Opens New Scientific Research Window for Discoveries and Novel Insights in Functional Structural Biology and Disease Biology
Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics
Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of Over 400 Microorganisms from Positive Blood Cultures
Honeywell Expands Life Sciences and Software Capabilities through Acquisition of Sparta Systems
Hoppen Commended by Frost & Sullivan for Improving Patient Experience with its Best-in-Class Infotainment Solutions for Smart Hospitals
Syntellix Lauded by Frost & Sullivan for Breakthrough Technology in the Orthopedic & Trauma Market with its Bioresorbable Orthopedic Implant, MAGNEZIX
Aspect Imaging Lauded by Frost & Sullivan for its Revolutionary Embrace® Neonatal MRI System

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)